Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | APLNR | P35414 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isothiocyanate SCHEMBL17289573 | 0.93 | KEAP1 (0.32) | KEAP1NFE2L2NAAA | |
| SCHEMBL11053867 | 0.90 | — | — | |
| SCHEMBL6538414 | 0.84 | — | — | |
| (Isothiocyanatomethyl)Cyclohexane SCHEMBL1448756 | 0.82 | KEAP1 (0.42) | KEAP1NFE2L2NAAAAPLNR | |
| SCHEMBL2143495 | 0.78 | APLNR (0.36) | KEAP1NFE2L2NAAAAPLNR | |
| SCHEMBL569528 | 0.78 | — | — | |
| SCHEMBL26614265 | 0.78 | APLNR (0.36) | KEAP1NFE2L2NAAAAPLNR | |
| SCHEMBL20462167 | 0.78 | ALDH1A1 (0.31) | — | |
| SCHEMBL43488 | 0.78 | ALDH1A1 (0.31) | — | |
| SCHEMBL1069199 | 0.78 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250032470-A1 | Electrophilic Androgen Receptor (AR) Antagonists for AR Downregulation and Ferroptosis Induction in Cancer Cells | WAYNE STATE UNIVERSITY (US) | 2025-01-30 | — | — | US | claimed |
| EP-3743453-A1 | SORBITOL-BASED CROSSLINKED OPTICAL POLYMERS | Novol, Inc. (US) | 2020-12-02 | — | — | EP | claimed |
| US-20200354507-A1 | SORBITOL-BASED CROSSLINKED OPTICAL POLYMERS | NOVOL, INC. | 2020-11-12 | — | — | US | claimed |
| US-10696778-B1 | Methods of making polymers using isosorbide | NOVOL, INC. (US) | 2020-06-30 | — | — | US | claimed |
| WO-2019147848-A1 | SORBITOL-BASED CROSSLINKED OPTICAL POLYMERS | NOVOL, INC. (US) | 2019-08-01 | — | — | WO | claimed |
| US-20250032470-A1 | Electrophilic Androgen Receptor (AR) Antagonists for AR Downregulation and Ferroptosis Induction in Cancer Cells | WAYNE STATE UNIVERSITY (US) | 2025-01-30 | — | — | US | disclosed |
| US-12133846-B2 | Electrophilic androgen receptor (AR) antagonists for AR downregulation and ferroptosis induction in cancer cells | WAYNE STATE UNIVERSITY (US) | 2024-11-05 | — | — | US | disclosed |
| US-11780950-B1 | Methods of making polymers using isosorbide | Bhatia, Monica (US) | 2023-10-10 | — | — | US | disclosed |
| CN-111205424-B | Modified resin and resin composition | 旭化成株式会社 | 2022-04-08 | — | — | CN | disclosed |
| EP-3572202-B1 | MOLDED ARTICLE AND METHOD FOR PRODUCING SAME | SUMITOMO CHEMICAL CO (JP) | 2021-08-11 | — | — | EP | disclosed |
| US-10941254-B2 | Molded article and method of producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-03-09 | — | — | US | disclosed |
| EP-3743453-A1 | SORBITOL-BASED CROSSLINKED OPTICAL POLYMERS | Novol, Inc. (US) | 2020-12-02 | — | — | EP | disclosed |
| US-20110021916-A1 | ORGANIC PIEZOELECTRIC MATERIAL, ULTRASONIC OSCILLATOR USING THE MATERIAL, METHOD FOR MANUFACTURING THE ULTRASONIC OSCILLATOR, ULTRASONIC PROBE, AND ULTRASONIC MEDICAL DIAGNOSTIC IMAGING DEVICE | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2011-01-27 | — | — | US | disclosed |
| US-20110004102-A1 | ORGANIC PIEZOELECTRIC MATERIAL, ULTRASONIC OSCILLATOR USING THE SAME, METHOD FOR PRODUCING THE ULTRASONIC OSCILLATOR, ULTRASONIC PROBE AND ULTRASONIC MEDICAL DIAGNOSTIC IMAGING DEVICE | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2011-01-06 | — | — | US | disclosed |
| EP-1319966-B1 | COMPOSITION FOR OPTICAL MATERIAL | MITSUBISHI GAS CHEMICAL CO (JP) | 2010-05-26 | — | — | EP | disclosed |
| US-20100029890-A1 | POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION CONTAINING THE SAME, POLYTHIOURETHANE RESIN OBTAINED FROM THE COMPOSITION, AND PROCESS FOR PRODUCING THE RESIN | MITSUI CHEMICALS, INC. (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2065414-A1 | POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION CONTAINING THE CATALYST, POLYTHIOURETHANE RESIN OBTAINED FROM THE COMPOSITION, AND METHOD FOR PRODUCING THE RESIN | Mitsui Chemicals, Inc. (JP) | 2009-06-03 | — | — | EP | disclosed |
| US-7009031-B2 | Composition for optical material | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 2006-03-07 | — | — | US | disclosed |
| US-20040024165-A1 | Composition for optical material | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 2004-02-05 | — | — | US | disclosed |
| EP-1319966-A1 | COMPOSITION FOR OPTICAL MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2003-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029890-A1 | POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION CONTAINING THE SAME, POLYTHIOURETHANE RESIN OBTAINED FROM THE COMPOSITION, AND PROCESS FOR PRODUCING THE RESIN | OXGR1, HRH3, HRH4 | KEAP1 1787/4885NFE2L2 2663/4885NAAA 2822/4885 |
| US-12133846-B2 | Electrophilic androgen receptor (AR) antagonists for AR downregulation and ferroptosis induction in cancer cells | AR, GSR, GPX1 | KEAP1 11/4885NFE2L2 17/4885NAAA 842/4885 |
| US-11780950-B1 | Methods of making polymers using isosorbide | PUF60, MACF1, PPIE | KEAP1 1133/4885NFE2L2 3136/4885NAAA 1464/4885 |
| US-20250032470-A1 | Electrophilic Androgen Receptor (AR) Antagonists for AR Downregulation and Ferroptosis Induction in Cancer Cells | AR, GSR, GPX1 | KEAP1 11/4885NFE2L2 17/4885NAAA 842/4885 |
| US-10696778-B1 | Methods of making polymers using isosorbide | PUF60, MACF1, PPIE | KEAP1 938/4885NFE2L2 3237/4885NAAA 1529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.